http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2010149311-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 |
| filingDate | 2009-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2012-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2010149311-A |
| titleOfInvention | THERAPEUTIC USEFUL SUBSTITUTED 1,7-DIPHENYL-1,2,3,5,6,7-HEXAHYDROPYRIDO [3,2,1-ij] QUINOLINE COMPOUNDS |
| abstract | 1. The compound represented by the structural formula:! ! where n and o independently represent 0, 1, 2 or 3; ! R1 independently represents H or a substituent having the formula C0-12H0-30N0-3O0-5P0-2S0-3F0-6Cl0-3Br0-3I0-3; ! Z represents O or S; ! X represents O, S or NR2; ! R and R2 independently represent hydrogen or a C1-6 hydrocarbon residue; and! B has the formula C0-12H1-30N0-3O0-5P0-2S0-3F0-6Cl0-3Br0-3I0-3 and represents hydrogen, a hydrocarbon residue, a heterohydrocarbon residue, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, or a combination thereof, where if X is NR2, then B and R2 can together form a ring or ring system. ! 2. The compound according to claim 1, where X represents O.! 3. The compound of claim 2, wherein B is not methyl or ethyl. ! 4. The compound of claim 2, wherein B has at least 3 carbon atoms. ! 5. The compound according to claim 1, where X represents NR2. ! 6. The compound according to claim 1, where R1 represents H, C1-3 alkyl, F, Cl, Br, I, OH, CN or CF3. ! 7. The compound according to claim 5, where n is 0.! 8. The compound according to claim 6, additionally represented by the structural formula:! ! 9. The compound of claim 8, where Z represents O.! 10 The compound of claim 9, wherein B is C1-6alkyl, C1-6alkenyl, C1-6alkynyl, C1-6haloalkyl, phenyl, benzyl, furylmethyl, or where XB is morpholino. ! 11. The compound of claim 10, selected from:! ,,,! ,,,! ,,,! ,,,! ,,,! ,,,! ,,,! ,,,! , and. ! 12. The compound of claim 8, where Z is S.! 13. The compound of claim 12, wherein B is C1-6 alkyl, C1-6 alkenyl, C1-6 alkynyl, C1-6 haloalkyl, phenyl, benzyl, furylmethyl, or where XB is morpholino. ! 14. A method for treating a disease or condition in which |
| priorityDate | 2008-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 37.